Breakthrough Hormone FGF19 Unleashes Hidden Fat-Burning Potential
Multi-Source Journalism
This article synthesizes reporting from multiple credible news sources to provide comprehensive, balanced coverage.
Multi-Source Journalism
This article synthesizes reporting from multiple credible news sources to provide comprehensive, balanced coverage.
Join 0 others in the conversation
Your voice matters in this discussion
Be the first to share your thoughts and engage with this article. Your perspective matters!
Discover more articles
Scientists have discovered a natural hormone called FGF19 that may unlock a powerful new mechanism to combat obesity by triggering the brain to burn more energy and activate fat-burning cells. Research suggests that FGF19 enhances thermogenesis, redu
Scientists studying aging in a tiny worm have discovered that sensory inputs like touch and smell can override the benefits of dietary restriction on lifespan, revealing a complex interplay between the brain, metabolism, and environment. This breakth
New research highlights the significant weight loss benefits of GLP-1 drugs like Ozempic, but raises concerns about their long-term safety and accessibility. Three Cochrane reviews found these medications to be effective in promoting weight loss, but
Scientists have discovered a hidden "backup heater" within brown fat that enables the body to burn calories and boost metabolism, even when primary energy systems are impaired. This novel mechanism, found in mice, could lead to safer and more effecti
Researchers have discovered that specific gut bacteria in mice play a crucial role in maintaining a lean physique, raising hopes that similar findings could apply to humans. This groundbreaking study suggests a potential link between gut microbiome a
Scientists have discovered a molecule called betaine that mimics the anti-aging effects of exercise, potentially paving the way for a pill to slow aging. Research found that the kidneys play a crucial role in releasing betaine, which restores balance
Eli Lilly's trillion-dollar valuation is largely driven by its lucrative weight-loss and diabetes medications, Mounjaro and Zepbound, which have generated billions in revenue and been approved to reduce heart attack and stroke risk in overweight indi
Two new oral medications for obesity, containing the active ingredient semaglutide, are nearing FDA approval, offering a potential alternative to weekly injectable treatments like Wegovy. These pills, developed by Novo Nordisk and Eli Lilly, may prov
Scientists have uncovered a crucial link between brain energy signaling and mental health, discovering that a disrupted ATP energy signal in the hippocampus may drive both depression and anxiety. Research in mice found that lowered ATP levels, caused
Researchers have made a groundbreaking discovery in fat metabolism, revealing a previously unknown role for the HSL protein in regulating fat cell function. This finding, which shows that HSL not only breaks down fat but also maintains the health of
Scientists have discovered a previously unknown "backup heater" within brown fat tissue that enables the body to burn excess calories and boost metabolism, even when other energy systems are impaired. This hidden system, found in mice, could potentia
Scientists have discovered a "backup heater" within brown fat tissue that helps the body burn calories and boost metabolism, even when other energy systems slow down. This novel finding could lead to safer and more effective ways to combat obesity an
The billion-dollar weight-loss industry is abuzz with the success of GLP-1 agonist drugs like Mounjaro and Zepbound, but recent studies have raised concerns about their effectiveness and safety, particularly in pregnant individuals and those with Alz
Researchers have found a strong link between body composition and brain health, discovering that individuals with more muscle mass and lower levels of deep abdominal fat tend to have biologically younger brains. This correlation suggests that maintai
Researchers are raising concerns about the limitations and potential risks of GLP-1 agonist weight-loss drugs, including their effectiveness for Alzheimer's patients and potential complications during pregnancy. Meanwhile, the trillion-dollar valuati
Researchers at the University of Utah Health have made a groundbreaking discovery in treating acute kidney injury, a life-threatening condition affecting millions worldwide. By targeting ceramides, fatty molecules that damage kidney cells' energy-pro
Researchers have found a correlation between muscle mass and reduced deep abdominal fat, and a younger biological brain age. The study, presented at the Radiological Society of North America, suggests that individuals with more muscle and lower visce
Scientists have discovered a natural hormone called FGF19 that unlocks a previously unknown mechanism to burn fat and combat obesity. FGF19 triggers the brain to increase energy expenditure, activate thermogenic fat, and improve metabolic health by e
Researchers are grappling with the complexities of GLP-1 agonist weight-loss drugs, which have shown promise in improving heart and brain health, but also raise concerns about potential risks, including pregnancy complications and unexplained weight
Recent research on GLP-1 drugs, including Ozempic and Mounjaro, has confirmed their potential for significant weight loss, but raises concerns about long-term safety, potential side effects, and unequal global access to these treatments. Three Cochra
Get ready for a groundbreaking discovery that's got everyone buzzing - a next-gen cancer drug has been found to have a surprising side effect: slowing down aging. Researchers at Queen Mary University of London have discovered that the experimental dr
A recent study by Arizona State University has uncovered a potential silent threat to young brains, where a common nutrient deficiency and early metabolic strain may be quietly setting the stage for brain damage. The research found that young adults
In a week marked by significant developments in the weight-loss drug market, researchers are highlighting the need for further understanding of GLP-1 agonist drugs, citing concerns over their potential risks, including pregnancy complications and unf
Pioneering obesity pills, which mimic the effects of injectable GLP-1 medicines, are poised to hit the market, offering a promising alternative for millions of people struggling with weight management. These oral medications, which include a pill ver
Share & Engage Share
Share this article